文献速递肾癌与肾肿瘤

宿主因素对机器人部分肾切除术结局的影响:系统综述与荟萃分析

Impact of Host Factors on Robotic Partial Nephrectomy Outcomes: Comprehensive Systematic Review and Meta-Analysis.
PubMed 文献 · J Urol · 2018-05-03

该系统综述与荟萃分析纳入41项研究共10506例患者,评估肿瘤大小/复杂性、患者合并症等宿主因素对机器人部分肾切除术结局的影响。非复杂肿瘤、≤4cm肿瘤及非肾门肿瘤的手术时间、出血量、热缺血时间和并发症更少;高龄、异常BMI和慢性肾病与特定结局相关。

要点

  • 非复杂肿瘤较复杂肿瘤的手术时间、出血量、热缺血时间和并发症更少。
  • 肿瘤>4cm与更长手术时间、更多出血、输血、并发症和住院时间相关。
  • 肾门肿瘤增加出血量、热缺血时间和中转开放风险,前后位置不影响结局。

核心结论

  • 机器人部分肾切除术结局受肿瘤和患者宿主因素影响,认识风险并优化患者选择有助于改善结局。

研究设计与样本

  • 遵循PRISMA和AHRQ指南的系统综述与荟萃分析,检索PubMed、Scopus和Web of Science(2000年1月1日至2017年6月31日)。
  • 纳入41项研究共10506例患者,使用加权均数差和比值比比较连续与二分类变量。

主要发现

  • 非复杂肿瘤较复杂肿瘤的手术时间(WMD -44.95,p=0.003)、估计出血量(WMD -160,p<0.003)、热缺血时间(WMD -8.56,p≤0.00001)和术后并发症(OR 0.42,p=0.01)更少。
  • 肿瘤>4cm与更长手术时间(WMD 30.11,p≤0.00001)、更多估计出血量(WMD 39.26;95%CI 28.77,49.74;p≤0.00001)、热缺血时间(WMD 5.17,p≤0.00001)、输血(OR 3.15,p=0.003)、术后并发症(OR 1.88,p=0.004)和住院时间(WMD 0.56,p=0.0004)相关。
  • 肾门肿瘤与更多估计出血量(WMD 51.34,p=0.03)、热缺血时间(WMD 8.17,p≤0.00001)和中转开放部分肾切除术(OR 14.14,p=0.006)相关;肿瘤前后位置不影响结局。
  • 年龄≥70岁患者估计肾小球滤过率下降百分比和总死亡率有非显著升高趋势;异常BMI与更长手术时间(WMD 13.47,p<0.001)、更多出血量(WMD 45.44,p<0.0001)和术后并发症(OR 1.48,p=0.03)相关。
  • 慢性肾病队列术后估计肾小球滤过率下降百分比更小(WMD 7.16;95%CI 2.74,11.59;p=0.002)但术后并发症增加(OR 2.05;95%CI 1.47,2.85)。

关键数值与推荐

  • 非复杂肿瘤术后并发症OR 0.42(p=0.01)。
  • 肿瘤>4cm输血OR 3.15(p=0.003),术后并发症OR 1.88(p=0.004)。
  • 肾门肿瘤中转开放OR 14.14(p=0.006)。
  • 异常BMI术后并发症OR 1.48(p=0.03)。
  • 慢性肾病术后并发症OR 2.05(95%CI 1.47,2.85)。

临床怎么用

  • 术前根据肿瘤复杂性和大小、肾门位置、BMI及慢性肾病状态评估机器人部分肾切除术风险。
  • 对高风险宿主因素患者加强围手术期管理并个体化选择手术方式。

局限性

  • 纳入研究为观察性设计,可能存在混杂和选择偏倚。
  • 部分分析异质性未详细报告,摘要未提供敏感性分析结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Host factors (tumor size/complexity, patient comorbidities) impact outcomes of robotic partial nephrectomy. We report a comprehensive systematic review and meta-analysis to critically evaluate the impact of host factors on operative, perioperative, functional, oncologic and survival outcomes of robotic partial nephrectomy. MATERIALS AND METHODS: All full text English language publications on robotic partial nephrectomy comparing host factors were evaluated. We followed the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) statement and AHRQ (Agency for Healthcare Research and Quality) guidelines to evaluate PubMed®, Scopus® and Web of Science® databases (January 1, 2000 to June 31, 2017). Weighted mean difference and odds ratio were used to compare continuous and dichotomous variables, respectively. Sensitivity analyses were performed as needed. To condense the sheer volume of analyses the data are presented using novel summary forest plots. This study is registered with PROSPERO, number CRD42017062712. RESULTS: Our meta-analysis evaluated 41 studies including 10,506 patients. In terms of tumor factors, compared to patients with complex tumors, those with noncomplex tumors had lesser operating room time (WMD -44.95, p=0.003), estimated blood loss (WMD -160, p <0.003), warm ischemia time (WMD -8.56, p ≤0.00001) and postoperative complications (OR 0.42, p=0.01). Tumors larger than 4 cm were associated with greater operating room time (WMD 30.11, p ≤0.00001), estimated blood loss (WMD 39.26; 95% CI 28.77, 49.74; p ≤0.00001), warm ischemia time (WMD 5.17, p ≤0.00001), transfusions (OR 3.15, p=0.003), postoperative complications (OR 1.88, p=0.004) and length of stay (WMD 0.56, p=0.0004). Hilar tumors involved greater estimated blood loss (WMD 51.34, p=0.03), warm ischemia time (WMD 8.17, p ≤0.00001) and conversion to open partial nephrectomy (OR 14.14, p=0.006). Tumor location, anterior vs posterior, did not impact robotic partial nephrectomy outcomes. As for patient factors, older patients (70 years or older) trended nonsignificantly toward greater percentage decrease of estimated glomerular filtration rate and overall mortality. The abnormal body mass index cohort reported greater operating room time (WMD 13.47, p <0.001), estimated blood loss (WMD 45.44, p <0.0001) and postoperative complications (OR 1.48, p=0.03). The chronic kidney disease cohort had a lesser reduction in postoperative percentage estimated glomerular filtration rate (WMD 7.16; 95% CI 2.74, 11.59; p=0.002) and increased postoperative complications (OR 2.05; 95% CI 1.47, 2.85). CONCLUSIONS: Robotic partial nephrectomy outcomes are impacted by host factors, including tumor and patient characteristics. Awareness of this increased risk and its mitigation with expert patient selection are important for excellent robotic partial nephrectomy outcomes. Our meta-analysis provides comprehensive, objective, summary data of 10,506 patients, detailing discrete outcomes for discrete host factors to better inform urologists and patients considering robotic partial nephrectomy.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Cacciamani GE, Gill T, Medina L, et al. Impact of Host Factors on Robotic Partial Nephrectomy Outcomes: Comprehensive Systematic Review and Meta-Analysis. J Urol. 2018. PMID: 29730203. doi:10.1016/j.juro.2018.04.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。